RAS mutations and their correlation with survival of patients with advanced pancreatic adenocarcinoma.

被引：0
|
作者：
Almeida, Thiago Lins
Gomes, Jessica Ribeiro
Cesar Machado, Marcel Cerqueira
Buzaid, Antonio C.
Maluf, Fernando C.
机构：
[1] Antonio Ermirio Moraes Oncol Ctr, Sao Paulo, Brazil
[2] Ctr Oncol Antonio Ermirio Moraes, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
325
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Molecular analysis of RAS genes mutations in patients with cervical adenocarcinoma.
    Ingles Garces, Alvaro Henrique
    Pimenta Inada, Haynna Kimie
    Mora, Paulo
    Torres, Michelle
    de Almeida, Fabio Marques
    Longatto-Filho, Adhemar
    Villa, Luisa Lina
    Rebouas Moreira, Marise Amaral
    Ferreira, Carlos G. M.
    De Melo, Andreia Cristina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] KRAS Mutations and Their Correlation With Survival of Patients With Advanced Pancreatic Cancer
    Bournet, Barbara
    Muscari, Fabrice
    Guimbaud, Rosine
    Cordelier, Pierre
    Buscail, Louis
    PANCREAS, 2013, 42 (03) : 543 - 544
  • [3] A novel RAS inhibitor for pancreatic ductal adenocarcinoma.
    Arshad, Tariq
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16263 - E16263
  • [4] Time intervals to diagnosis and chemotherapy do not influence survival outcome in patients with advanced pancreatic adenocarcinoma.
    Laurent-Badr, Q.
    Barbe, C.
    Brugel, M.
    Hautefeuille, V
    Volet, J.
    Grelet, S.
    Desot, E.
    Botsen, D.
    Deguelte, S.
    Pitta, A.
    Abdelli, N.
    Brasseur, M.
    De Mestier, L.
    Neuzillet, C.
    Bouche, O.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (06) : 658 - 667
  • [5] Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma and pancreatic adenocarcinoma.
    Baretti, Marina
    Durham, Jennifer N.
    Walker, Rosalind
    Mitcheltree, Amber-Lynn
    Christmas, Brian
    Cope, Leslie
    Jaffee, Elizabeth M.
    Azad, Nilofer Saba
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] A triple approach strategy for patients with locally advanced pancreatic adenocarcinoma.
    Cantore, M.
    Girelli, R.
    Mambrini, A.
    Frigerio, I.
    Boz, G.
    Simoncini, E.
    Lusenti, A.
    Orlandi, M.
    Bassi, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] Efficacy and safety of FOLFIRINOX in elderly patients with advanced pancreatic adenocarcinoma.
    Jung, Jae Hyup
    Kang, Jingu
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Effect of metformin on survival in pancreatic ductal adenocarcinoma.
    Amin, Sunil
    Mhango, Grace
    Lin, Jenny J.
    Aronson, Anne
    Boffetta, Paolo
    Wisnivesky, Juan P.
    Lucas, Aimee
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [9] Analysis of lipogenic and metabolic subtypes and survival outcome in patients with pancreatic adenocarcinoma.
    Kundranda, Madappa N.
    Chand, Nischal Mahaveer
    Barrett, J. Carl
    Moser, James
    Grund, Eric M.
    Tekumalla, Poornima K.
    Miller, Gregory M.
    Narain, Niven R.
    Modur, Vijay
    Kiebish, Michael A.
    Ramanathan, Ramesh K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 775 - 775
  • [10] Complement levels as predictors of survival in pancreatic adenocarcinoma.
    Sohal, Davendra
    Lin, Feng
    Kundu, Suman
    McCrae, Keith
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345